TCL Archive Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority September 14, 1979
TCL Archive Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects March 17, 1978
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
